Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Chemistry

A subscription to JoVE is required to view this content.
You will only be able to see the first 2 minutes.

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies
 

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies

Article DOI: 10.3791/52521
February 12th, 2015

Chapters

Summary February 12th, 2015

Due to its multi-day radioactive half-life and favorable decay properties, the positron-emitting radiometal 89Zr is extremely well-suited for use in antibody-based radiopharmaceuticals for PET imaging. In this protocol, the bioconjugation, radiosynthesis, and preclinical application of 89Zr-labeled antibodies will be described.

Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter